Tests of platelet function

Current Opinion in Hematology

Volumn 14, Issue 5, 2007, Pages 432-437

  Shah, Usman ^a   Ma, Alice D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Electron microscopy; Flow cytometry; PFA 100; Platelet aggregation; Platelet function; Platelet secretion

Indexed keywords

ABCIXIMAB; ADENINE NUCLEOTIDE; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EPTIFIBATIDE; RISTOCETIN; THROMBOXANE RECEPTOR STIMULATING AGENT; TICLOPIDINE; TIROFIBAN; U 46612; UNCLASSIFIED DRUG; VASODILATOR AGENT;

BLEEDING TIME; DIAGNOSTIC TEST; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; REVIEW; SCREENING TEST; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE RELEASE REACTION; THROMBOELASTOGRAPHY;

BLOOD PLATELETS; CELL SHAPE; HEMORRHAGE; HUMANS; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; THROMBOSIS;

EID: 34648815153     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3282b9747b     Document Type: Review

References (39)

1. Michaelson A, editor. Platelets. 2nd ed. New York: Academic Press; 2006. A comprehensive and fairly updated review of platelet function testing in addition to disorders of platelet function.
2. Brinkhous KM. W. W. Duke and his bleeding time test: a commentary on platelet function. JAMA 1983; 250:1210-1214.
3. Favaloro EJ. Laboratory identification of von Willebrand disease: technical and scientific perspectives. Semin Thromb Hemost 2006; 32:456-471. An excellent review of the limitations and strengths of the PFA-100.
4. Peterson P, Hayes TE, Arkin CF, et al. The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg 1998; 133:134-139.
5. Lind SE. Prolonged bleeding time. Am J Med 1984; 77:305-312.
6. Kratzer MA, Born GV. Simulation of primary haemostasis in vitro. Haemostasis 1985; 15:357-362.
7. Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzer: PFA-100. Semin Thromb Hemost 1995; 21 (Suppl 2):106-112.
8. Mammen EF, Alshameeri RS, Comp PC. Preliminary data from a field trial of the PFA-100 system. Semin Thromb Hemost 1995; 21 (Suppl 2):113-121.
9. Haubelt H, Anders C, Vogt A, et al. Variables influencing platelet function analyzer-100 closure times in healthy individuals. Br J Haematol 2005; 130:759-767.
10. Franchini M. The platelet-function analyzer (PFA-100) for evaluating primary hemostasis. Hematology 2005; 10:177-181.
11. Harrison P. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults. Br J Haematol 2005; 130:3-10.
12. Suzuki S, Morishita S. The relationship between the onset of labor mechanisms and the hemostatic system. Immunopharmacology 1999; 43:133-140.
13. Hayward CP, Harrison P, Cattaneo M, et al. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4:312-319. A systematic review of the use of the PFA-100 in evaluating platelet disorders, by the Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
14. Favaloro EJ. The utility of the PFA-100 in the identification of von Willebrand disease: a concise review. Semin Thromb Hemost 2006; 32:537-545. Reviews the studies of the use of the PFA-100 in diagnosing vWD.
15. Favaloro EJ. Clinical application of the PFA-100. Curr Opin Hematol 2002; 9:407-415.
16. Koscielny J, Ziemer S, Radtke H, et al. A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10:195-204.
17. Koscielny J, von Tempelhoff GF, Ziemer S, et al. A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10:155-166.
18. Michelson AD, Frelinger AL 3rd, Furman MI. Current options in platelet function testing. Am J Cardiol 2006; 98 (10A):4N-10N.
19. Peerschke EI, Silver RT, Weksler BB, et al. Examination of platelet function in whole blood under dynamic flow conditions with the cone and plate(let) analyzer: effect of erythrocytosis and thrombocytosis. Am J Clin Pathol 2007; 127:422-428.
20. Savion N, Varon D. Impact: the cone and plate(let) analyzer: testing platelet function and antiplatelet drug response. Pathophysiol Haemost Thromb 2006; 35:83-88.
21. Fritsma GA. Platelet function testing: aggregometry and lumiaggregometry. Clin Lab Sci 2007; 20:32-37.
22. White MM, Foust JT, Mauer AM, et al. Assessment of lumiaggregometry for research and clinical laboratories. Thromb Haemost 1992; 67:572-577.
23. Zhou L, Schmaier AH. Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field. Am J Clin Pathol 2005; 123:172-183.
24. Nozaki H, Nagao T, Arimori S. Platelet volume and intraplatelet adenine nucleotides in various hematologic disorders. Eur J Haematol 1988; 40:65-68.
25. Michelson AD, Furman MI. Laboratory markers of platelet activation and their clinical significance. Curr Opin Hematol 1999; 6:342-348.
26. Papalambros E, Sigala F, Travlou A, et al. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment. J Am Coll Surg 2004; 199:69-77.
27. Harrison P. Platelet function analysis. Blood Rev 2005; 19:111-123.
28. Vitale M, Tazzari P, Ricci F, et al. Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia. Cytometry 2001; 46:290-295.
29. Jy W, Mao WW, Horstman LL, et al. A flow cytometric assay of platelet activation marker P-selectin (CD62P) distinguishes heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT). Thromb Haemost 1999; 82:1255-1259.
30. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis 2001; 12:327-337.
31. Cammerer U, Dietrich W, Rampf T, et al. The predictive value of modified computerized thromboelastography and platelet function analysis for post-operative blood loss in routine cardiac surgery. Anesth Analg 2003; 96:51-57.
32. Kang YG, Martin DJ, Marquez J, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985; 64:888-896.
33. Spiess BD, Tuman KJ, McCarthy RJ, et al. Thromboelastography as an indicator of postcardiopulmonary bypass coagulopathies. J Clin Monit 1987; 3:25-30.
34. Hobson AR, Agarwala RA, Swallow RA, et al. Thrombelastography: current clinical applications and its potential role in interventional cardiology. Platelets 2006; 17:509-518.
35. Zuckerman L, Cohen E, Vagher JP, et al. Comparison of thrombelastography with common coagulation tests. Thromb Haemost 1981; 46:752-756.
36. Traverso CI, Caprini JA, Arcelus JI. Application of thromboelastography in other medical and surgical states. Semin Thromb Hemost 1995; 21 (Suppl 4):50-52.
37. White JG. Use of the electron microscope for diagnosis of platelet disorders. Semin Thromb Hemost 1998; 24:163-168.
38. Lorez HP, Richards JG, Da Prada M, et al. Storage pool disease: comparative fluorescence microscopical, cytochemical and biochemical studies on aminestoring organelles of human blood platelets. Br J Haematol 1979; 43:297-305.
39. Seri M, Pecci A, Di Bari F, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 2003; 82:203-215.